|
Name
|
Auflagedatum
|
Volumen
|
YTD-P
|
1-Y-P
|
3-Y-P
|
5-Y-P
|
|
HBM UCITS (Lux) Funds - HBM Global Biotechnology Fund
LU1540961759
USD / Acc. / Retail
|
30.12.2011
14,6 Jahre
|
22,59 |
+13,96% |
+59,29% |
+62,23% |
+40,95% |
|
Polar Capital Funds PLC - Biotechnology Fund
IE00B42Z4531
USD / Dist. / Retail
|
31.10.2013
12,7 Jahre
|
3.321,52 |
+23,15% |
+82,02% |
+99,07% |
+101,28% |
|
Invesco NASDAQ Biotech UCITS ETF
IE00BQ70R696
USD / Acc. / Retail
|
06.11.2014
11,7 Jahre
|
406,70 |
+18,31% |
+59,80% |
+55,37% |
+34,86% |
|
Protea Fund - Sectoral Biotech Opportunities Fund
LU1176840327
USD / Acc. / Retail
|
27.02.2015
11,4 Jahre
|
26,52 |
+9,99% |
+52,76% |
+37,64% |
+14,77% |
|
PPF ("PMG Partners Funds") - Helix Biotechnology Fund
LU1230343250
USD / Acc. / Retail
|
21.10.2015
10,8 Jahre
|
35,34 |
+31,26% |
+93,36% |
+61,61% |
+4,96% |
|
Aescap Life Sciences
NL0012343958
EUR / Acc. / Retail
|
29.03.2016
10,3 Jahre
|
144,33 |
+14,46% |
+82,72% |
+75,69% |
+25,19% |
|
iShares Nasdaq US Biotechnology UCITS ETF
IE00BYXG2H39
USD / Acc. / Retail
|
19.10.2017
8,8 Jahre
|
935,51 |
+18,29% |
+59,69% |
+55,32% |
+34,77% |
|
L&G Pharma Breakthrough UCITS ETF
IE00BF0H7608
USD / Acc. / Retail
|
18.01.2018
8,5 Jahre
|
17,90 |
+12,40% |
+45,00% |
+31,83% |
+17,33% |
|
Janus Henderson Horizon Biotechnology Fund
LU1897414303
USD / Acc. / Retail
|
10.12.2018
7,6 Jahre
|
1.751,54 |
+20,79% |
+87,62% |
+98,19% |
+120,21% |
|
JPMorgan Funds - Thematics - Genetic Therapies Fund
LU2050612402
USD / Acc. / Retail
|
24.10.2019
6,8 Jahre
|
354,68 |
+17,62% |
+56,04% |
+19,19% |
-24,24% |